Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00217399 | Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00470847 | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | completed | Phase 1 | 35 | Nancy Lin, MDOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01335152 | Online Stress Management and Coping Skills Training for Women With Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Talaria, IncINDUSTRY | 1 | May 7, 2014 | clinicaltrials |
| NCT00645333 | Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 4, 2014 | clinicaltrials |
| NCT00724386 | Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer | completed | Phase 1 | 26 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00068614 | HER-2 Protein Vaccine in Treating Women With Breast Cancer | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00513058 | Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 33 | UNICANCEROTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00496665 | ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer | completed | Phase 1 | 25 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00316875 | Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 23 | Northwestern UniversityOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00290732 | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | completed | Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00004156 | Vaccine Therapy in Treating Patients With Breast Cancer | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01230671 | The Physical and Psychological Benefits of Yoga and Breast Cancer | completed | Phase 1 | 80 | Dr. Sarkis MeterissianOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00983424 | Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer | completed | Phase 1 | 14 | Northwestern UniversityOTHER | 1 | Sep 16, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00574301 | Percutaneous Removal and Margin Ablation for Breast Cancer | completed | Phase 1 / Phase 2 | 32 | University of ArkansasOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00039052 | Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer | completed | Phase 1 | — | Neurocrine BiosciencesINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004174 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | completed | Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00096057 | Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 24 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004925 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00674791 | Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease | completed | Phase 1 | 13 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020332 | Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00020852 | Cryosurgery in Treating Women With Breast Lesions | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00099008 | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women | completed | Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00007891 | Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | — | Cancer Research Institute of Contra CostaOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | completed | Phase 1 / Phase 2 | — | Chugai PharmaceuticalINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00245024 | Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT01216033 | Exploratory Study of Breast Cancer With ABY025(ABY0125) | completed | Phase 1 / Phase 2 | 7 | Biomedical Radiation SciencesOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00304096 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 1 | 12 | University of VirginiaOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00003184 | Vaccine Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | — | Providence Cancer Center, Earle A. Chiles Research InstituteOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00060372 | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00014430 | Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer | completed | Phase 1 | 13 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT00680758 | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 18 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00721370 | Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer | completed | Phase 1 | 12 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT01116297 | Tissue Oxygenation Measurements With Modulated Light (S-FLARE) | completed | Phase 1 | 4 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00270907 | CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer | completed | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 28, 2014source: clinicaltrials